AiTiA AiTiALVSD Medical AI
A software as a medical device analyzes 12-lead ECG data using artificial intelligence to indicate the likelihood of left ventricular systolic dysfunction(heart failure) with scores and risk assessment.
In South Korea, over 40 tertiary and secondary hospitals, as well as the largest health checkup hospital network, are using AiTiALVSD.
[What is LVSD(heart failure)]
Heart failure is a syndrome where the heart can't supply enough blood to the body's tissues due to structural and functional abnormalities. Heart failure is classified based on the ejection fraction from the left ventricle with each heartbeat.
[User Benefit]
- Diagnosing LVSD(heart failure) with just a 12-lead ECG
- AUROC of 91.9% in confirmatory clinical trials
- Can be used immediately in conjunction with compatible ECG machines
- Early screening is possible even in asymptomatic patient groups
[Others]
- Korea gov. declared reimbursement for AiTiALVSD(Apr 28, 2023)
- 29th Breakthrough Device from KFDA(Feb 16, 2023)